SCHEMBL18319615

SCHEMBL18319615

CC(C)(C)[S@@+]([O-])/N=C1\C2(CCN(C(=O)O)CC2)CCC1(CO)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18319616 1.00 — —
SCHEMBL23826992 0.75 — —
SCHEMBL28900028 0.75 — —
SCHEMBL23826837 0.75 — —
SCHEMBL18322988 0.74 — —
SCHEMBL18322986 0.74 — —
SCHEMBL19641150 0.73 AVPR1A (0.34) —
SCHEMBL22799231 0.69 — —
SCHEMBL22799234 0.69 — —
SCHEMBL22799232 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3310774-A1 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Novartis AG (CH) 2018-04-25 — — EP disclosed
WO-2016203406-A1 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2016-12-22 — — WO disclosed
Send feedback